Product Categories
Country: | United States |
---|---|
Tel: | +1-781-999-5354 |
Mobile: | +1-00000000000 |
E-mail: | info@targetmol.com |
QQ: | |
Skype: | Chat Now! |
Address: | 36 Washington Street, Wellesley Hills |
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
|
Product Name | MF | CAS | Details |
---|
DGN462 | C53H59N5O9S | 1394079-41-4 | Details |
DHMEQ racemate;rel-DHMEQ | C13H11NO5 | 287194-38-1 | Details |
DHODH-IN-1 | C21H20F3N3O2 | 1800296-63-2 | Details |
Mifepristone;RU 38486;C-1073;RU486 | C29H35NO2 | 84371-65-3 | Details |
DHODH-IN-11 | C15H11N3O2 | 1263303-95-2 | Details |
DHODH-IN-12 | C10H9N3O2 | 1263303-93-0 | Details |
DHODH-IN-13 | C10H6F3N3O3 | 1364791-86-5 | Details |
DHODH-IN-14 | C15H7F4N3O3 | 1364791-93-4 | Details |
DHODH-IN-15 | C15H11N3O3 | 1364791-88-7 | Details |
hDHODH-IN-3;DHODH-IN-2 | C18H19BrN4O2 | 1644156-80-8 | Details |
DHODH-IN-3 | C17H13ClN2O2 | 1148126-04-8 | Details |
DHODH-IN-4 | C17H12Cl2N2O2 | 1148125-93-2 | Details |
hDHODH-IN-4;DHODH-IN-5 | C21H24N4O2 | 1644156-56-8 | Details |
hDHODH-IN-5;DHODH-IN-7 | C21H21F3N2O2 | 2029049-77-0 | Details |
Aminoglutethimide;DL-Aminoglutethimide;NSC-330915;BA-16038 | C13H16N2O2 | 125-84-8 | Details |
DHODH-IN-8 | C17H13ClN2O2 | 1148126-03-7 | Details |
hDHODH-IN-7;DHODH-IN-9 | C21H23FN4O | 1644156-41-1 | Details |
DHPG;(RS)-3,5-DHPG | C8H9NO4 | 146255-66-5 | Details |
DI-591 | C31H47N5O4S | 2245887-38-9 | Details |
Di-O-methyldemethoxycurcumin | C22H22O5 | 824951-60-2 | Details |
diABZI STING agonist-1 (Tautomerism) | C42H51N13O7 | 2138498-18-5 | Details |
Diacetolol D7 | C16H24N2O4 | 1346604-19-0 | Details |
Diacylglycerol acyltransferase inhibitor-1 | C21H23N5O2 | 1610800-25-3 | Details |
Dibutyryl-cGMP sodium;Bt2cGMP sodium | C18H23N5NaO9P | 51116-00-8 | Details |
Didesethyl chloroquine;Bisdesethylchloroquine | C14H18ClN3 | 4298-14-0 | Details |
Paromomycin Sulfate;Paromomycin sulfate salt;Aminosidine sulfate | C23H47N5O18S | 1263-89-4 | Details |
Dihydro Dutasteride | C27H32F6N2O2 | 164656-22-8 | Details |
Dihydro-β-erythroidine hydrobromide;DHβE hydrobromide | C16H21NO3.BrH | 29734-68-7 | Details |
Dihydrocytochalasin B | C29H39NO5 | 39156-67-7 | Details |
Dihydroergocristine mesylate;DHEC (mesylate) | C36H45N5O8S | 24730-10-7 | Details |
Dihydromunduletone;DHM | C25H28O6 | 674786-20-0 | Details |
Dimethyl fumarate-d6;Dimethyl fumarate D6;DMF D6 | C6H2D6O4 | 66487-95-4 | Details |
DiosMetin 7-O-β-D-Glucuronide | C22H20O12 | 35110-20-4 | Details |
DIPQUO | C20H17N3O | 1269365-82-3 | Details |
Diprotin A TFA;Ile-Pro-Pro (TFA) | C19H32F3N3O6 | 209248-71-5 | Details |
Penfluridol;R-16341;TLP-607 | C28H27ClF5NO | 26864-56-2 | Details |
Dipyrocetyl | C11H10O6 | 486-79-3 | Details |
DIQ3 | C23H15N5 | 2258636-02-9 | Details |
Disitertide;P144 | C68H109N17O22S2 | 272105-42-7 | Details |
DJ001 | C15H12N2O3 | 2161305-12-8 | Details |
DL-Norvaline;2-Aminopentanoic acid | C5H11NO2 | 760-78-1 | Details |
DL-TBOA | C11H13NO5 | 205309-81-5 | Details |
DLK-IN-1 | C20H24F3N5O2 | 1620574-24-4 | Details |
DM3-SMe | C38H54ClN3O10S2 | 796073-70-6 | Details |
DM3;Maytansinoid DM3 | C37H52ClN3O10S | 796073-54-6 | Details |
DM4-SMe | C39H56ClN3O10S2 | 796073-68-2 | Details |
Afalanine;N-Acetyl-DL-phenylalanine | C11H13NO3 | 2901-75-9 | Details |
DMAPT;Dimethylamino Parthenolide | C17H27NO3 | 870677-05-7 | Details |
DMCM hydrochloride | C17H19ClN2O4 | 1215833-62-7 | Details |
dmDNA31 | C50H62N4O13 | 845625-44-7 | Details |
DMT1 blocker 1 | C16H14N4O2 | 1354790-56-9 | Details |
DMT1 blocker 2 | C16H13N3O | 1062648-63-8 | Details |
DMU2105 | C18H13NO | 1821143-79-6 | Details |
DMU2139 | C19H15NO2 | 1821143-80-9 | Details |
VX-984;M9831 | C23H23N7O | 1476074-39-1 | Details |
DNA31 | C48H58N4O13 | 845626-57-5 | Details |
DO-264 | C23H20Cl2F3N5O2S | 2301866-59-9 | Details |
Sarafloxacin hydrochloride;A-56620 HCl;Sarafloxacin HCl;A-56620 (hydrochloride) | C20H18ClF2N3O3 | 91296-87-6 | Details |
DO34 analog | C26H28F3N5O4 | 2098969-71-0 | Details |
DO34 | C26H28F3N5O4 | 1848233-58-8 | Details |
Dofequidar fumarate;MS-209 | C34H35N3O7 | 153653-30-6 | Details |
Dofetilide D4;UK 68789 D4 | C19H27N3O5S2 | 1189700-56-8 | Details |
Dofetilide N-oxide;UK-116856 | C19H27N3O6S2 | 144449-71-8 | Details |
Donitriptan | C23H25N5O2 | 170912-52-4 | Details |
Dooku1 | C13H9Cl2N3OS | 2253744-54-4 | Details |
Dopamine D2 receptor antagonist-1 | C14H17N3S | 1055411-77-2 | Details |
MC-DOXHZN;Doxorubicin(6-maleimidocaproyl)hydrazone | C37H42N4O13 | 151038-96-9 | Details |
(Z)-Capsaicin;Zucapsaicin;cis-Capsaicin;Civamide | C18H27NO3 | 25775-90-0 | Details |
Aldoxorubicin;DOXO-EMCH;INNO-206 | C37H42N4O13 | 1361644-26-9 | Details |
DPPH;2,2-Diphenyl-1-picrylhydrazyl | C18H12N5O6* | 1898-66-4 | Details |
Doxylamine D5 succinate | C21H28N2O5 | 1216840-94-6 | Details |
DPBQ | C24H14N2O2 | 7029-89-2 | Details |
NMI 8739 | C30H41NO3 | 129024-87-9 | Details |
Nithiamide;Aminitrozole;CL-5279 | C5H5N3O3S | 140-40-9 | Details |
Dopropidil | C20H35NO2 | 79700-61-1 | Details |
Deschloroclozapine | C18H20N4 | 1977-07-7 | Details |
Dot1L-IN-1 | C32H36ClN9O2S | 2088518-50-5 | Details |
Dot1L-IN-2 | C27H24N8O | 1940206-71-2 | Details |
DOTAP chloride;1,2-Dioleoyl-3-trimethylammonium-propane chloride | C42H80ClNO4 | 132172-61-3 | Details |
DOV-216,303 Free Base | C11H11Cl2N | 66504-40-3 | Details |
Doxepin D3 Hydrochloride | C19H19ClD3NO | 347840-07-7 | Details |
DS18561882 | C28H31F3N4O6S | 2227149-22-4 | Details |
DS-1040 Tosylate | C23H35N3O5S | 1335138-89-0 | Details |
Drobuline hydrochloride | C19H26ClNO | 68162-52-7 | Details |
Meclizine dihydrochloride;Meclizine 2HCl;NSC28728;Meclozine dihydrochloride | C25H29Cl3N2 | 1104-22-9 | Details |
Droxicainide | C16H24N2O2 | 78289-26-6 | Details |
Droloxifene;3-Hydroxytamoxifen | C26H29NO2 | 82413-20-5 | Details |
DRAK2-IN-1 | C21H20N4O3 | 871837-60-4 | Details |
DRI-C21045 | C32H24N2O7S | 2101765-81-3 | Details |
DREADD agonist 21 | C17H18N4 | 56296-18-5 | Details |
DS08210767 | C31H39N5O2 | 2376334-75-5 | Details |
DUB-IN-1 | C20H11N5O | 924296-18-4 | Details |
Pralidoxime Chloride;2-PAM (chloride);2-Pyridinealdoxime methochloride;2-PAM chloride | C7H9ClN2O | 51-15-0 | Details |
DU717 | C12H15ClN4O2S | 59943-31-6 | Details |
DSR-6434 | C19H28N8O2 | 1059070-10-8 | Details |
DSP-1053 | C26H32BrNO4 | 1176326-76-3 | Details |
DS21360717 | C21H23N7O | 2304654-43-9 | Details |
DS88790512 | C22H29N3O2 | 2231089-95-3 | Details |
DSP-0565 | C14H12FNO | 1226855-28-2 | Details |
Product Total: Product Page: | ||||
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 |